approval · primary record
HEPARIN SODIUM
3 approval events · latest 2025-09-24
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2025-09-24 |
| Approval events | 3 |
| Brand | HEPARIN SODIUM |
| Sponsor | PFIZER |
| Route | INJECTION |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2025-09-24 | FDA | NDA | HEPARIN SODIUM | PFIZER | INJECTION |
| 2025-03-25 | FDA | NDA | HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | B BRAUN | INJECTION |
| 2024-12-19 | FDA | NDA | DEFENCATH | CORMEDIX | N/A |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:30:27.673Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:heparin-sodium
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Heparin Sodium · compound